Alzheimer’s trial to test drug on people without symptoms to see if it can be prevented
Published

Healthy middle-aged people deemed to be at higher risk of developing condition among those eligible to participate People without memory loss will be offered an experimental Alzheimer’s drug that could stop the development of the condition before dementia symptoms emerge.
Havoc links to the original reporting. The full story stays with the publisher.